On the safety of breast implants

Recent media attention and controversy coupled with the FDA's product review have prompted a reappraisal of the potential health risks of silicone breast implants. The pertinent literature on this subject is reviewed and it is concluded that: 1.1. There is no evidence, clinical or otherwise, of carcinogenesis resulting from their use. 2.2. At present there is no conclusive evidence that they cause autoimmune disease but the increasing number of anecdotal reports of connective tissue disease in women who have been the recipients of such implants merits further investigation. 3.3. Postoperative technical and mechanical problems such as implant deflation, perforation, rupture, creasing or palpable folds may occasionally be encountered. Other complications of such surgery include capsular contracture and rarely, infection. These complications may require surgical revision, explantation, or implant exchange but do not in themselves make breast implants dangerous. 4.4. Silicone implants can safely be used in humans.